BioNTech
BNTX
37 hedge funds and large institutions have $384M invested in BioNTech in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 1 closing their positions.
1,800% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 1
95% more funds holding
Funds holding: 19 → 37 (+18)
34% more capital invested
Capital invested by funds: $286M → $384M (+$98.2M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.82% less ownership
Funds ownership: 3.74% → 2.92% (-0.82%)
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
+$18.8M |
| 2 |
AWM
Avitas Wealth Management
Los Angeles,
California
|
+$1.3M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$778K |
| 4 |
Jane Street
New York
|
+$516K |
| 5 |
Morgan Stanley
New York
|
+$480K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$60.2M |
| 2 |
AG
Artal Group
Luxembourg
|
-$15.6M |
| 3 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$8.45M |
| 4 |
Millennium Management
New York
|
-$5.16M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$4.59M |
BNTX Hedge Fund Activity: Q1 2020 in Review
37 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q1 2020, worth a combined $384M — up 34% from $286M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new BNTX positions and 1 closed out — a net gain of 18 holders — while 6 added to existing stakes and 10 trimmed.
The largest buyer was Primecap Management, adding an estimated $18.8M. The largest seller was Fidelity Investments, cutting an estimated $60.2M.
- 37 institutional investors held BioNTech (BNTX) as of Q1 2020, up from 19 in Q4 2019.
- Funds reported $384M of BioNTech stock for Q1 2020, up 34% quarter-over-quarter.
- 19 funds opened new BioNTech positions in Q1 2020 and 1 closed out, a net change of +18 holders.
- The largest BioNTech buyer in Q1 2020 was Primecap Management, an estimated $18.8M added.
- The largest BioNTech seller in Q1 2020 was Fidelity Investments, an estimated $60.2M sold.
Based on aggregated 13F filings for Q1 2020.